As SEPT9 and SEPT2 knockdowns suppressed the GBM cell growth in a synergistic manner, we speculate that overexpression of one Septin gene could compensate for the loss of another in GBM cells. This evidence concerns the gene SEPTIN9 and glioblastoma.